The people of Memorial Sloan Kettering Cancer Center (MSK) are united by a singular mission: ending cancer for life. Our specialized care teams provide personalized, compassionate, expert care to patients of all ages. Informed by basic research done at our Sloan Kettering Institute, scientists across MSK collaborate to conduct innovative translational and clinical research that is driving a revolution in our understanding of cancer as a disease and improving the ability to prevent, diagnose, and treat it. MSK is dedicated to training the next generation of scientists and clinicians, who go on to pursue our mission at MSK and around the globe. One of the world’s most respected comprehensive centers devoted exclusively to cancer, we have been recognized as one of the top two cancer hospitals in the country by U.S. News & World Report for more than 30 years.
In compliance with applicable State regulatory authorities, COVID-19 vaccination is mandatory for all MSK staff. Staff are considered fully vaccinated upon completion of a primary vaccination series for COVID-19 (i.e., one dose of a single dose vaccine or a final dose of a multi-dose vaccine series). Exceptions from the COVID-19 vaccine requirement are permitted for those who request and receive an approved medical or fully remote exemption. Requests for medical exemption can take up to two weeks to review. Vaccination or an approved medical exemption is required to start work.
Note: Individuals are eligible to receive a COVID-19 booster two months after completion of a primary vaccination series for COVID-19. Because vaccine-induced immunity can wane over time, MSK continues to strongly urge all staff to get a COVID-19 booster as soon as they become eligible to maintain their protective immunity for a longer period.
Post-doctoral fellowship investigating mechanisms of immune tolerance. Work in the Brown laboratory addresses how the tissue microenvironment and microbiota shape immune development, and the mechanisms by which distinct antigen-presenting cells instruct tolerance to self and foreign antigens vs immunity to pathogens. Recent work from the lab defined the cell types and mechanisms that instruct peripheral regulatory T cell development and tolerance to the gut microbiota. This work uncovered a novel lineage of antigen-presenting cells, including two subsets of extra-thymic Aire-expressing cells, enriched during early life. The investigation of a novel lineage of tolerogenic antigen-presenting cells represents an exciting area of investigation with important translational implications. As such, this field will provide a fantastic opportunity for a highly-motivated and ambitious young scientist to establish their future independent and competitive research niche. The Brown Lab is a highly collaborative and supportive environment, committed to training a diverse group of scientists. The post-doctoral fellow will be supported in fellowship applications and receive support for professional development activities, training courses and attendance at conferences.
The Brown Lab is located in the state-of-the art Zuckerman Research Center, in the heart of the Upper East Side, New York City. The ZRC is embedded in the Tri-Institutional Campus, encompassing Memorial Sloan Kettering Cancer Center, the Weill Cornell Medical College, and the Rockefeller University. The post-doctoral fellow will be part of this dynamic community of scientists, with frequent networking and career development opportunities. Dr. Brown is an Assistant Attending in the Department of Pediatrics, and work in the lab transitions between mechanistic studies in experimental models and translational human immunology studies. Memorial Sloan Kettering Cancer Center (MSK) is one of the world’s premier cancer centers, committed to exceptional patient care, leading-edge research, and superb educational programs.
Dr. Chrysothemis Brown is an Assistant Member, MSK, and Assistant Professor, Weill Cornell Graduate School of Medical Sciences. Dr. Brown received the NIH/NIAID DP2 New Innovator Award (2022), Josie Robertson Investigator Award (2021) and V Foundation Pediatric Scholar Award (2022). As a Parker Senior Fellow, Dr. Brown is also supported by the Parker Institute for Cancer Immunotherapy.
Lab website: www.thebrownlaboratory.com
The ideal candidate should have a passion for science and be creative, adventurous, and collegial in their approach to scientific discovery.
MSK is an equal opportunity and affirmative action employer committed to diversity and inclusion in all aspects of recruiting and employment. All qualified individuals are encouraged to apply and will receive consideration without regard to race, color, gender, gender identity or expression, sexual orientation, national origin, age, religion, creed, disability, veteran status or any other factor which cannot lawfully be used as a basis for an employment decision.
Federal law requires employers to provide reasonable accommodation to qualified individuals with disabilities. Please tell us if you require a reasonable accommodation to apply for a job or to perform your job. Examples of reasonable accommodation include making a change to the application process or work procedures, providing documents in an alternate format, using a sign language interpreter, or using specialized equipment.